|
|
| |
Etoposide Capsules USP 50 mg |
| |
Small cell lung cancer
Testicular Cancer
Bladder cancer
Malignant Lymphomas of Hodgkin's & Non-Hodgkin's type
Acute Leukemia
Gestational trophoblastic tumor
Paediatric Sarcoma especially Ewing's sarcoma
|
| |
Etoposide in combination therapy with other
approved chemotherapeutic agents is :
50-100mg/m2/day on days 1-5 to be repeated every 3-4 weeks.
Alternately day schedule of 100-125 mg/m2 on days 1, 3 & 5 is also employed commonly.
General Oral Dosage : 100-200 mg/m2/day.
Dosage Adjustment :
Renal Impairment : Required.
Hepatic Impairment : Required. |
| |
Packing : |
10 Strips of 10 Capsules |
|
|
